A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.46 USD -2.76% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amneal Intermediate Inc
Net Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Net Income
-$48.7m
CAGR 3-Years
N/A
CAGR 5-Years
25%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Income
$38B
CAGR 3-Years
29%
CAGR 5-Years
22%
CAGR 10-Years
8%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income
-$6.5B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income
-$2.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income
$13.8B
CAGR 3-Years
55%
CAGR 5-Years
8%
CAGR 10-Years
9%
Eli Lilly and Co
NYSE:LLY
Net Income
$7.3B
CAGR 3-Years
7%
CAGR 5-Years
-1%
CAGR 10-Years
8%

See Also

What is Amneal Intermediate Inc's Net Income?
Net Income
-48.7m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Net Income amounts to -48.7m USD.

What is Amneal Intermediate Inc's Net Income growth rate?
Net Income CAGR 5Y
25%

Over the last year, the Net Income growth was 81%.

Back to Top